DE69906389D1 - Verfahren zur herstellung von citalopram - Google Patents

Verfahren zur herstellung von citalopram

Info

Publication number
DE69906389D1
DE69906389D1 DE69906389T DE69906389T DE69906389D1 DE 69906389 D1 DE69906389 D1 DE 69906389D1 DE 69906389 T DE69906389 T DE 69906389T DE 69906389 T DE69906389 T DE 69906389T DE 69906389 D1 DE69906389 D1 DE 69906389D1
Authority
DE
Germany
Prior art keywords
citalopram
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69906389T
Other languages
English (en)
Other versions
DE69906389T2 (de
Inventor
Hans Petersen
Harold Rock
Henrik Svane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Application granted granted Critical
Publication of DE69906389D1 publication Critical patent/DE69906389D1/de
Publication of DE69906389T2 publication Critical patent/DE69906389T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Materials Engineering (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
DE69906389T 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram Expired - Lifetime DE69906389T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900920 1999-06-25
PCT/DK1999/000640 WO2000013648A2 (en) 1999-06-25 1999-11-22 Method for the preparation of citalopram

Publications (2)

Publication Number Publication Date
DE69906389D1 true DE69906389D1 (de) 2003-04-30
DE69906389T2 DE69906389T2 (de) 2003-10-30

Family

ID=8099035

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69906389T Expired - Lifetime DE69906389T2 (de) 1999-06-25 1999-11-22 Verfahren zur herstellung von citalopram
DE19983487A Expired - Fee Related DE19983487C1 (de) 1999-06-25 1999-11-22 Verfahren zur Herstellung von Citalopram

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19983487A Expired - Fee Related DE19983487C1 (de) 1999-06-25 1999-11-22 Verfahren zur Herstellung von Citalopram

Country Status (36)

Country Link
US (2) US20020077353A1 (de)
EP (1) EP1159274B1 (de)
JP (1) JP3447267B2 (de)
KR (1) KR100491368B1 (de)
CN (2) CN1140521C (de)
AR (1) AR020863A1 (de)
AT (3) ATE235478T1 (de)
AU (2) AU1374500A (de)
BG (1) BG65574B1 (de)
BR (1) BR9917368B1 (de)
CA (2) CA2290127C (de)
CH (1) CH691305A5 (de)
CZ (1) CZ292198B6 (de)
DE (2) DE69906389T2 (de)
DK (2) DK1159274T3 (de)
EA (1) EA002560B1 (de)
ES (2) ES2194545T3 (de)
FI (1) FI108641B (de)
GB (2) GB2354239B (de)
HK (1) HK1049002B (de)
HU (1) HUP0103235A3 (de)
IL (2) IL145959A0 (de)
IS (1) IS2343B (de)
IT (1) ITMI991581A1 (de)
MX (1) MXPA01010989A (de)
NO (1) NO328542B1 (de)
NZ (1) NZ514979A (de)
PL (1) PL205579B1 (de)
PT (1) PT1159274E (de)
SE (1) SE516690C2 (de)
SI (1) SI1159274T1 (de)
SK (1) SK285813B6 (de)
TR (1) TR200103702T2 (de)
UA (1) UA63034C2 (de)
WO (1) WO2000013648A2 (de)
ZA (1) ZA200108854B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039112A1 (en) 1998-12-23 2000-07-06 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
PL198024B1 (pl) 1999-04-14 2008-05-30 Lundbeck & Co As H Sposób wytwarzania citalopramu, związki pośrednie i ich zastosowanie do wytwarzania citalopramu
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ATE355268T1 (de) 1999-10-25 2006-03-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
WO2000012044A2 (en) 1999-10-25 2000-03-09 H. Lundbeck A/S Method for the preparation of citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
SI1246812T1 (en) 1999-12-28 2004-08-31 H. Lundbeck A/S Method for the preparation of citalopram
WO2001049672A1 (en) 1999-12-30 2001-07-12 H. Lundbeck A/S Method for the preparation of citalopram
CZ20022601A3 (cs) 2000-01-14 2002-10-16 H. Lundbeck A/S Způsob výroby 5-kyanoftalidu
FR2805812A1 (fr) 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
EP1265883A1 (de) 2000-03-13 2002-12-18 H. Lundbeck A/S Verfahren zur herstellung von citalopram
EA200200968A1 (ru) * 2000-03-13 2003-02-27 Х.Лундбекк А/С Поэтапное алкилирование 5-замещенных 1-(4-фторфенил)-1,3-дигидроизобензофуранов
PT1265882E (pt) 2000-03-14 2004-06-30 Lundbeck & Co As H Metodo para preparacao de citalopram; composto e citalopram
CN1418206A (zh) * 2000-03-16 2003-05-14 H·隆德贝克有限公司 5－氰基－1－(4－氟苯基)－1,3－二氢异苯并呋喃的制备方法
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
AU2001272368A1 (en) * 2000-07-06 2002-01-21 H. Lundbeck, A/S Method for the preparation of citalopram
CA2354877C (en) * 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
IL147226A (en) * 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure cithalopram
ATE222899T1 (de) * 2000-12-28 2002-09-15 Lundbeck & Co As H Verfahren zur herstellung von reinem citalopram
EP1355897A1 (de) 2001-01-30 2003-10-29 Orion Corporation Fermion Verfahren zur herstellung von 1-(3-dimethylaminopropyl)-1-(4-fluorphenyl)-1,3-dihydrobenzofuran-5-carbonitrile
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
WO2002072565A1 (en) * 2001-03-09 2002-09-19 Ranbaxy Laboratories Limited Process for the preparation of citalopram
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
TWI306846B (en) 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
KR101166280B1 (ko) 2004-08-23 2013-11-27 썬 파마 글로벌 에프제트이 시탈로프램 및 에난티오머의 제조 방법
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2017271A1 (de) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Verfahren zur Herstellung von Escitalopram

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (de) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) * 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
EP1015416B1 (de) * 1997-07-08 2001-09-19 H. Lundbeck A/S Verfahren zur herstellung von citalopram
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CZ292911B6 (cs) * 1997-11-11 2004-01-14 H. Lundbeck A/S Způsob výroby citalopramu
EA002977B1 (ru) * 1998-10-20 2002-12-26 Х.Лундбекк А/С Способ получения циталопрама
WO2000039112A1 (en) * 1998-12-23 2000-07-06 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
PL198024B1 (pl) * 1999-04-14 2008-05-30 Lundbeck & Co As H Sposób wytwarzania citalopramu, związki pośrednie i ich zastosowanie do wytwarzania citalopramu
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
WO2000012044A2 (en) * 1999-10-25 2000-03-09 H. Lundbeck A/S Method for the preparation of citalopram
AR026063A1 (es) * 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
FR2805812A1 (fr) * 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
CA2354877C (en) * 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
IL147226A (en) * 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure cithalopram
ATE222899T1 (de) * 2000-12-28 2002-09-15 Lundbeck & Co As H Verfahren zur herstellung von reinem citalopram

Also Published As

Publication number Publication date
IS5861A (is) 2001-02-23
FI20010155A (fi) 2001-02-09
EA002560B1 (ru) 2002-06-27
NO328542B1 (no) 2010-03-15
GB2357761B (en) 2001-09-05
ITMI991581A1 (it) 2001-01-15
SK285813B6 (sk) 2007-08-02
CZ2001320A3 (en) 2001-05-16
DK200100060A (da) 2001-04-10
GB0101504D0 (en) 2001-03-07
GB2357761A (en) 2001-07-04
IL145959A0 (en) 2002-07-25
FI108641B (fi) 2002-02-28
US20020077353A1 (en) 2002-06-20
PL346237A1 (en) 2002-01-28
ES2194545T3 (es) 2003-11-16
BG65574B1 (bg) 2009-01-30
SE516690C2 (sv) 2002-02-12
AU2001100440B4 (en) 2002-01-24
UA63034C2 (en) 2004-01-15
DK1159274T3 (da) 2003-07-21
KR100491368B1 (ko) 2005-05-24
CA2290127A1 (en) 2000-12-25
ES2189699A1 (es) 2003-07-01
PT1159274E (pt) 2003-08-29
DE69906389T2 (de) 2003-10-30
EP1159274A2 (de) 2001-12-05
IS2343B (is) 2008-02-15
NO20010319L (no) 2001-02-23
WO2000013648A3 (en) 2000-07-13
CA2290127C (en) 2005-01-25
GB2354239B (en) 2001-06-06
DE19983487C1 (de) 2002-07-25
JP2002526386A (ja) 2002-08-20
SI1159274T1 (en) 2003-10-31
IL145959A (en) 2007-07-24
HUP0103235A3 (en) 2003-01-28
AR020863A1 (es) 2002-05-29
HK1049002A1 (en) 2003-04-25
NO20010319D0 (no) 2001-01-19
AT4365U1 (de) 2001-06-25
HUP0103235A2 (hu) 2002-01-28
MXPA01010989A (es) 2002-06-04
ITMI991581A0 (it) 1999-07-15
ATA904199A (de) 2002-05-15
CZ292198B6 (cs) 2003-08-13
WO2000013648A8 (en) 2000-05-11
AU2001100440A4 (en) 2001-11-01
CN1140521C (zh) 2004-03-03
CN1502616A (zh) 2004-06-09
BR9917368B1 (pt) 2010-02-09
AT409961B (de) 2002-12-27
GB0105182D0 (en) 2001-04-18
EP1159274B1 (de) 2003-03-26
SE0100193D0 (sv) 2001-01-24
EA200101072A1 (ru) 2002-02-28
HK1049002B (zh) 2004-12-31
CH691305A5 (de) 2001-06-29
CA2475401A1 (en) 2000-12-25
NZ514979A (en) 2004-01-30
WO2000013648B1 (en) 2001-03-15
PL205579B1 (pl) 2010-05-31
TR200103702T2 (tr) 2002-06-21
JP3447267B2 (ja) 2003-09-16
ZA200108854B (en) 2002-08-28
BR9917368A (pt) 2002-03-05
WO2000013648A2 (en) 2000-03-16
CN1367786A (zh) 2002-09-04
AU1374500A (en) 2000-03-27
BG106191A (en) 2002-08-30
ATE235478T1 (de) 2003-04-15
SK18402001A3 (sk) 2002-06-04
GB2354239A (en) 2001-03-21
SE0100193L (sv) 2001-04-25
KR20020012204A (ko) 2002-02-15
US20090088469A1 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
DE19983486T1 (de) Verfahren zur Herstellung von Citalopram
DE69906389T2 (de) Verfahren zur herstellung von citalopram
DE60035029D1 (de) Verfahren zur herstellung von furfural
DE122007000077I1 (de) Verfahren zur Herstellung von substituierten Octanoyl-Amiden
DE60106933D1 (de) Verfahren zur herstellung von citalopram
DE69930540D1 (de) Verfahren zur herstellung von silalkylen-siloxancopolymeren
DE50001027D1 (de) Verfahren zur Herstellung von substituierten Olefinen
DE60019747D1 (de) Verfahren zur herstellung von fluorolefinen
DE60117106D1 (de) Verfahren zur Herstellung von Halopropyldimethylchlorosilanen
DE59808528D1 (de) Verfahren zur Herstellung von 3-Glycidyloxypropyltrialkoxysilanen
DE60026607T8 (de) Verfahren zur Herstellung von Perfluoralkadienen
DE50103049D1 (de) Verfahren zur Herstellung von Aminodiphenylaminen
DE60133280D1 (de) Verfahren zur herstellung von citalopram
DE60002784D1 (de) Verfahren zur Herstellung von Alkylhalogensilanen
DE60024372D1 (de) Verfahren zur Herstellung von Tetraorganooxysilanen
DE69935355D1 (de) Verfahren zur Herstellung von Citalopram
DE60031231D1 (de) Verfahren zur Herstellung von 2-Alkyl-4-Isothiazolin-3-onen
DE60004119D1 (de) Verfahren zur Herstellung von Pentaacetyl-beta-D-Glucopyranose
DE59902434D1 (de) Verfahren zur Herstellung von Isochroman-3-onen
DE50003603D1 (de) Verfahren zur Herstellung von Bistrifluormethylbenzylaminen
DE60019763D1 (de) Verfahren zur herstellung von thiazolderivaten
DE60119491D1 (de) Verfahren zur herstellung von acetylamidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamiden
DE60002513D1 (de) Verfahren zur Herstellung von Dimethyltetralin
DE50006464D1 (de) Verfahren zur Herstellung von Arylaminohydroxyanthrachinonen
DE50001772D1 (de) Verfahren zur Herstellung von Nitrodiphenylaminen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition